Latest On-Demand Webinars

Mucosal barriers are the gateways to all internal organs, serving to transport oxygen, nutrients, and waste and at the same time performing enormous feats of protection against infection and other hazardous insults. The explosion of interest in the human microbiome – especially but not only that in the gut – has driven new interest in building human mucosal barrier models.

During this webinar, we will discuss our hiPSC-derived cardiomyocytes and a custom service we provide for their electrophysiological characterization using microelectrode arrays (MEA). The focus is on the development of disease models and cardiotoxicity screening.

Watch this webinar to find out more about models designed for cell-to-cell interactions and fragment-based libraries.

Watch this webinar to discover more about the uses of bioscreening methodologies and how they are beneficial to the user.

Metastatic disease is the leading cause of mortality in patients with solid tumors. Despite decades of research, we only partially understand the underlying cellular and molecular mechanisms.

Current in vitro approaches for investigational toxicology, drug metabolism (DMPK) and safety are limited and are not fully representative of human response; therefore, drugs showing acceptable preclinical toxicity often fail in human clinical trials, and accurately predicting human drug exposure for new compounds is challenging and costly.

Microphysiological systems (MPS), or organ-on-chip (OOC) technologies, enable researchers to model human biology in the lab via 3D microtissue-based studies.

In these interviews from the KingFisher Symposium at ESHG 2019, discover more about the use of automated instruments in bioanalysis.